Total Payments
$297,807
2024 Payments
$1,853
Companies
19
Transactions
522
Medicare Patients
1,003
Medicare Billing
$122,800
Payment Breakdown by Category
Other$215,526 (72.4%)
Consulting$46,933 (15.8%)
Travel$21,483 (7.2%)
Food & Beverage$13,493 (4.5%)
Education$372.53 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $204,718 | 158 | 68.7% |
| Consulting Fee | $46,933 | 21 | 15.8% |
| Travel and Lodging | $21,483 | 126 | 7.2% |
| Food and Beverage | $13,493 | 205 | 4.5% |
| Honoraria | $10,765 | 7 | 3.6% |
| Education | $372.53 | 4 | 0.1% |
| Grant | $43.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $94,775 | 217 | $0 (2022) |
| Amgen Inc. | $70,721 | 115 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $38,728 | 53 | $0 (2021) |
| ABBVIE INC. | $20,555 | 26 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $19,700 | 24 | $0 (2021) |
| Allergan, Inc. | $19,634 | 33 | $0 (2021) |
| Lundbeck LLC | $12,962 | 15 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $7,870 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $7,562 | 8 | $0 (2019) |
| Promius Pharma LLC | $2,191 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,853 | 4 | Tonix Medicines, Inc. ($1,669) |
| 2023 | $993.97 | 8 | ABBVIE INC. ($694.99) |
| 2022 | $31,781 | 35 | ABBVIE INC. ($18,037) |
| 2021 | $54,939 | 68 | Biohaven Pharmaceuticals, Inc. ($19,700) |
| 2020 | $42,639 | 62 | Lilly USA, LLC ($23,493) |
| 2019 | $74,644 | 184 | Lilly USA, LLC ($39,880) |
| 2018 | $74,105 | 124 | Amgen Inc. ($35,171) |
| 2017 | $16,853 | 37 | Amgen Inc. ($10,936) |
All Payment Transactions
522 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $112.09 | General |
| Category: NEUROLOGY | ||||||
| 07/11/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: NEUROLOGY | ||||||
| 02/16/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $168.53 | General |
| Category: NEUROLOGY | ||||||
| 02/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $72.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $76.16 | General |
| Category: PAIN | ||||||
| 08/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $88.61 | General |
| Category: PAIN | ||||||
| 06/12/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $337.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $134.21 | General |
| Category: PAIN | ||||||
| 04/12/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $337.50 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2022 | Lilly USA, LLC | EMGALITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Neuroscience | ||||||
| 11/30/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2022 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $97.74 | General |
| Category: Neuroscience | ||||||
| 09/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: PRIMARY CARE | ||||||
| 09/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $125.40 | General |
| Category: PRIMARY CARE | ||||||
| 08/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: PRIMARY CARE | ||||||
| 08/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $108.26 | General |
| Category: PRIMARY CARE | ||||||
| 08/08/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $110.29 | General |
| Category: Neuroscience | ||||||
| 08/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $101.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 233 | 405 | $98,604 | $25,097 |
| 2022 | 5 | 238 | 525 | $131,079 | $33,454 |
| 2021 | 6 | 282 | 549 | $139,740 | $37,483 |
| 2020 | 7 | 250 | 438 | $112,590 | $26,766 |
Total Patients
1,003
Total Services
1,917
Medicare Billing
$122,800
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 78 | 139 | $29,051 | $9,384 | 32.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 39 | 77 | $31,647 | $6,706 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 62 | 99 | $14,058 | $4,229 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 27 | 29 | $8,120 | $2,846 | 35.1% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Facility | 2023 | 27 | 61 | $15,728 | $1,931 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 94 | 185 | $38,665 | $12,732 | 32.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 37 | 126 | $51,786 | $10,777 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 62 | 120 | $17,040 | $5,752 | 33.8% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Facility | 2022 | 24 | 73 | $17,708 | $2,256 | 12.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 21 | $5,880 | $1,937 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 99 | 187 | $39,083 | $13,009 | 33.3% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 45 | 117 | $48,087 | $10,848 | 22.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 40 | 46 | $12,880 | $4,889 | 38.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 52 | 96 | $13,632 | $4,693 | 34.4% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Facility | 2021 | 35 | 92 | $21,669 | $2,844 | 13.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $4,389 | $1,199 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 96 | 185 | $38,665 | $10,093 | 26.1% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 43 | 96 | $39,456 | $8,271 | 21.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 31 | 36 | $10,080 | $3,022 | 30.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 33 | 48 | $6,816 | $1,590 | 23.3% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Facility | 2020 | 24 | 49 | $11,650 | $1,565 | 13.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 12 | 12 | $4,788 | $1,472 | 30.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 12 | $1,135 | $752.61 | 66.3% |
About Dr. Duren Ready, MD
Dr. Duren Ready, MD is a Family Medicine healthcare provider based in Temple, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073581278.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duren Ready, MD has received a total of $297,807 in payments from pharmaceutical and medical device companies, with $1,853 received in 2024. These payments were reported across 522 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($204,718).
As a Medicare-enrolled provider, Ready has provided services to 1,003 Medicare beneficiaries, totaling 1,917 services with total Medicare billing of $122,800. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Temple, TX
- Active Since 03/14/2006
- Last Updated 12/22/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073581278
Products in Payments
- Aimovig (Biological) $46,061
- EMGALITY (Drug) $45,931
- AJOVY (Drug) $31,695
- NURTEC ODT (Drug) $27,869
- UBRELVY (Drug) $26,433
- REYVOW (Drug) $19,008
- VYEPTI (Biological) $12,962
- BOTOX (Biological) $8,884
- AIMOVIG (Biological) $7,562
- AJOVY (Biological) $6,738
- QULIPTA (Drug) $4,153
- Zembrace (Drug) $2,191
- ZEMBRACE SYMTOUCH (Drug) $1,669
- ONZETRA Xsail (Drug) $607.75
- BOTOX (Drug) $500.00
- BOTOX CHRONIC MIGRAINE (Drug) $218.40
- Xadago (Drug) $124.28
- ELYXYB - CELECOXIB (Drug) $112.80
- TECFIDERA (Drug) $106.50
- Trudhesa (Drug) $97.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Temple
David Willingham, M.d, M.D
Family Medicine — Payments: $11,118
Family Medicine $11,118
Dr. Rodney Lange, M.d, M.D
Family Medicine — Payments: $6,502
Family Medicine $6,502
Mr. Sam Samarrai, Md, MD
Family Medicine — Payments: $3,193
Family Medicine $3,193
Dr. Elizabeth Mattson, Md, MD
Family Medicine — Payments: $2,529
Family Medicine $2,529
Kelsey Pohler, Md, MD
Family Medicine — Payments: $2,444
Family Medicine $2,444
Dr. Roger Kylberg, Md, MD
Family Medicine — Payments: $1,962
Family Medicine $1,962